Inhipraz 40mg 10 Tablets

Babies: Not applicable. Lactating mothers: It is safe to use this medicine during breastfeeding. Studies have shown that the medicine does not cause harm to the baby. Pregnancy: It is unsafe to use this medicine during pregnancy.
Human studies have shown that the drug causes harmful effects on the developing baby. Seek the doctor's advice before using this medicine. Alcohol: It is unsafe to consume alcohol while taking this medicine. Driving: This medicine may cause dizziness, blurred vision, drowsiness and alters your ability to drive.
Do not drive if you experience these symptoms. Kidney: It is safe to use this medicine in patients with kidney disease.
Dose adjustment is not required. Seek a doctor's advice before taking this medicine. Liver: This medicine should be used with caution in patients with severe liver diseases.
Studies have shown that dose adjustment is required in these patients. Seek a doctor's advice before using this medicine..

Nausea Vomiting Stomach pain Dizziness Diarrhea.

Inhipraz belongs to the class of proton pump inhibitors used to treat heartburn, peptic ulcer, and gastroesophageal disease. It works by reducing excess production of acid in the stomach..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take this medicine on an empty stomach as prescribed by your doctor • To get better results to take this medicine at a fixed time • Finish the entire course of this medicine • Do not stop taking this medicine without consulting your doctor • If you experience diarrhoea, fever, and stomach pain for a longer duration, inform your doctor.

• Inhipraz + Atazanavir: Concurrent use may lead to a decrease in the absorption and blood levels of atazanavir • Inhipraz + Cefuroxime: Concurrent use may lead to a decrease in the absorption and blood levels of cefuroxime • Inhipraz + Dicumarol: Concurrent use may lead to an increase in the risk of bleeding • Inhipraz + Fenofibrate: Concurrent use may lead to an increase in the therapeutic effect of pantoprazole.